Diabetes-associated alterations in signal transduction pathways in smooth muscle

Biomedical Research (India)

Volumn 11, Issue 2, 2000, Pages 149-162

  Sakai, Yasushi ^a   Maruyama, Yoshiaki ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Diabetes; PKC; Signal transduction; Smooth muscle

Indexed keywords

EID: 3543002777     PISSN: 0970938X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (108)

1. Ozturk Y, Aitan VM and Ari NY. Effects of experimental diabetes and insulin on smooth muscle functions. Pharmacol Rev 1996; 48: 69-112.
2. Sakai Y, Kwan CY Calcium regulation and contractile dysfunction of smooth muscle. Biol Signals 1993; 2: 305-312
3. DCCT Research Group. The diabetes control and complications trial. N Engl J Med 1993; 329: 683-689.
4. Donnelly R, Qu X. Mechanisms of insulin resistance and new pharmacological approaches to metabolism and diabetic complications. Clin Exp Pharmacol Physiol 1998; 25: 79-87.
5. King GL, Shiba T, Oliver J., Inoguchi T, Burseil SE Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus. Annu Rev Med 1994; 45: 179-188.
6. Yasunari K, Kohno M, Kano H., Yokokawa K, Horio T, Yoshikawa J. Possible involvement of phospholipase D and protein kinase C in elevated glucose concentration induced vascular growth. Hypertension 1996; 28: 159-168.
7. Xia P, Inoguchi T, Kern T.D., Engerman RL, Oates PJ, King GL Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 1994; 43: 1122-1129.
8. Nobe K, Sakai Y, Momose K. Alternations of diacylglycerol kinase in streptozotocin-induced diabetic rats. Cell Signal 1998; 10: 465-471.
9. Shiba T, Inoguchi T, Sportsman R., Heath W, Bursell SE, King GL Correlation of diacylglycerol level and protein kinase C activity in rat retinato retinal circulation. Am J Physiol 1993; 265: E783-E793.
10. Wolf BA, Williamson JR, Easom R.A., Chang K., Sherman WR, Turk J. Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest 1991; 87: 31-38.
11. 2+ distribution. Diabetes 1999; 48: 1323-1330.
12. Kunisaki M, Bursell SE, Umeda F, Nawata H., King GL Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes 1994; 43: 1371-1377.
13. Hirano T, Niijima A. Effects of 2-deoxy-d-glucose, glucose and insulin on efferent activity in gastric vagues nerve. Experientia 1980; 36: 1197-1205.
14. Vaisman N, Wintrob N, Blumental A., Yosefsberg Z, Vardi P. Gastric emptying in patients with type 1 diabetes mellitus. Ann NY Acad Sci 1999; 20: 873: 506-511.
15. Barnett JL, Owyang C. Serum glucose concentration as a modulator of interdigestive gastric motility. Gastroenterology 1988; 94: 739-744.
16. Morgan LM, Tredger JA, Hampton S.M., French AP, Peake JC, Marks V. The effect of dietariy modification and gyperglycaemia on gastric emptying and gastric inhibitoriy polypeptide (GIP) secretion. Br J Nutri 1988; 60: 29-37
17. Singh J, Adeghate E, Salido G.M., Pariente JA, Yago MD, Juma LO Interaction of islet hormones with cholecystokinin octapeptide-evoked secretory responses in the isolated pancreas of normal and diabetic rats. Exp Physiol 1999; 84: 299-318.
18. Fraser R, Fuller J, Horowitz M., Dent J. Effect of insulin-indeuced hypoglycaemia on antral, pyloric and duodenal motility in fasting subjects. Clin Sci 1991; 81: 281-285.
19. Samsom M, Andre JP, Smout M. Abnormal Gastric and Small Intestinal Motor Funtion in Diabetes mellitus Dig Dis 1997; 15: 263-274.
20. Sakai Y, Inazu M, Aihara K., Inoue K, Homma I. Relations between contractile responses and β-adrenoceptos in gastric fundus of diabetic rats. Life Sci 1991; 48: 1043-1049.
21. Sakai Y, Inazu M, Shamoto A., Zhu BH, Homma I. Contractile hyperreactivity and alteration of PKC activity in gastric fundus smooth muscle of diabetic rats. Pharmacol Biochem Behv 1994; 49: 669-674.
22. Nishizuka Y Protein kinase C, lipid signaling of sustained cellular responses. FASEB J 1995; 9: 484-496.
23. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1993; 258: 607-614.
24. Jaken S, Leach K, Kluck T. Association of type 3 protein kinase C with focal contacts in rat embryo fibroblasts. J Cell Biol 1989; 109: 697-704.
25. Mochly RD, Henrich CJ, Cheever L, Khaner H., Simpson PC A protein kinase C isozyme is translocated to cytoskeletal elements on activation. Cell Reg 1991; 1: 693-706.
26. Leach KL, Powers EA, Ruff V.A., Jaken S., Kaufmann S. Type-3 protein kinase C localization to the nuclear envelope of phorbol ester treated NIH 3T3 cells. J Cell Biol 1989; 109: 685-695.
27. Haller H, Lindschau C, Quass P., Luft FC, Distler A. Angiotensin 11 and PDGF induce differential distribution of PKC isoforms in vascular smooth muscle cells. Hypertension 1994; 23: 848-852.
28. Irvine RF, Divecha N. Nuclear functions of protein kinase C. Semin. Cell Biol 1992; 3: 225-235.
29. Koya D, King GL Protein kinase C activation and the development of diabetic complication. Diabetes 1998; 47: 859-866.
30. Koya D, Lee IK, Ishii H, Kanoh H., King GL Prevention of glomerular dysfunctions in diabetic rats by treatment of d-a-tocopherol. J Am Soc Nephrol 1997; 803: 426-435.
31. 2+ Channels by glucose metabolism in mouse pancreatic β-cells. Nature 1989; 342: 550-553.
32. Sakai Y, Aihara K, Honda H., Inazu M. Calcium mobilization and phosphatidylinositol turnover in vas deferens smooth muscle of diabetic rats. Eur J Pharmacol 1989; 162: 475-481.
33. Wang R, Liu Y, Sauve R., Madhu G A-S. Hyperosmolaloty-induced abnormal patterns of calcium mobilization in smooth muscle cells from non-diabetic and diabetic rats. Mol and Cell Biochem 1998; 183: 79-85.
34. 2+ entry. Cell Calcium 1995; 17: 207-215
35. Makhlouf GM, Murthy KS Signal Transduction in Gastrointestinal Smooth Muscle. Cell Sig 1997; 9: 269-276
36. Abebe W, MacLeod KM Enhanced atrial contractility to noradrenaline in diabetic rats is associated with increased phosphoinositide metabolism. Can J Physiol Pharmacol 1991; 69: 355-361.
37. Murray P., Pitt B, Webb R.C. Ramipril prevents hypersensitivity to phenylephrine in aorta from streptozotocin-induced diabetic rats. Diabetologia 1994: 37: 664-670.
38. Pfaffman MA, Bal CA, Darby A, Human R. Insulin reversal of diabetes-induced inhibition of vascular contractility in the rat. Am J Physiol 1982; 242: H490-H495.
39. Sikorski BW, James GM, Glance S.D., Hodgson WC, King RG Effect of endothelium on diabetes-induced changes in constrictor responses mediated by 5-Hydroxytryptamine in rat aorta. J Cardiovasc Pharmacol 1993; 22: 423-430.
40. Ozturk Y, Ari NY, Altan VM Effect of lithium on gastro-intestinal complications in alloxan-diabetic rats. Gen Pharmacol 1992; 23: 769-773.
41. Sakai Y, Inazu M, Homma I. Contractile hyper-reactivity and Ca channel properties in vas deferens smooth muscle of diabetic rats. Chin J Pharmacol 1991; 5: 261-268.
42. Sakai Y, Honda H. Hyperactivity of Ca Channels in vasa deferentia smooth muscle of diabetic rats. Pharmacol. Biochem Behav 1987; 27: 227-229.
43. Longhurst PA, Brotcke TP Effects of castration and 'diabetes mellitus on cholinergic responsiveness and muscarinic receptors in the rat vas deferens. J Urol 1989; 141: 1225-1229.
44. Longhurst PA. In vitro contractile responses of vasa deferentia from spontaneously diabetic BB rats. J Auton Pharmacol 1991; 11: 63-71.
45. 2+ mobilization of the urinary bladder in streptozotocin-induced diabetic rats. Res Commun Chem Pathol Pharmacol 1992; 75: 143-158.
46. Fukomoto Y, Yoshida M, Weiss R.M., Latirpour J. Reversibility of diabetes- and diuresis-induced alteration in rat bladder dome muscarinic receptors. Diabetes 1994; 43: 819-826.
47. Mumtaz GH, Dashwood MR, Thompson C.S., Sullivan ME, Mikhailidis DP, Morgan RJ Increased expression of endothelin B receptors in the diabetic rabbit urinary bladder: functional relevance. BJU Int 1999; 83: 113-122
48. Sharma K, Wang L, Zhu Y., DeGuzman A, Cao GY, Lynn R.B., Joseph SK Renal type I inositol 1,4,5-trisphosphate receptor is reduced in streptozotocin- induced diabetic rats and mice. Am J Physiol 1999; 276: F54-F61.
49. Wang Z, Wu L, Wang R. Kinin B2 receptor-mediated contraction of tail arteries from normal or streptozotocin-induced diabetic rats. Br J Pharmacol 1998; 125: 143-151.
50. Williams B, Tsai P, Schrier RW Glucose-induced downregulation of angiotensin II and arginine vasopressin receptors in cultured rat aortic vascular smooth muscle cells. Role of protein kinase C J Clin. Invest 1992; 90: 1992-1999.
51. Abebe W, Harris KH, MacLeod KM Enhanced contractile responses of arteries from diabetic rats to alpha-adrenoceptor stimulation in the absence and presence of extracellular calcium. Cardiovasc Pharmacol 1990; 16: 239-248.
52. Inazu M, Sakai Y, Homma I. Contractile responses and calcium mobilization in renal arteries of diabetic rats. Eur J Pharmacol 1991; 203: 79-84.
53. Liu WS, Heckman CA The sevenfold way of PKC regulation. Cell Sig 1998; 10-8: 529-542
54. 2+ channel stimulation by intracellular ATP in guinea-pig basilar artery smooth muscle cells. J Physiol (Lond) 1997; 50: 311-317
55. Murthy KS, Makhlouf GM Agonist-mediated activation of phosphatidylcholine-specific phospholipase C and D in intestinal smooth muscle. Mol Pharmacol 1995; 48: 293-304.
56. Christensen FJ, Christensen FM, Delfino J.M., Stegmann T., Rasmussenn HJ J Biol Chem 1992; 267: 14783-14789.
57. Tolan D, Conway AM, Pyne N.J., Pyne S. Sphingosine prevents diacylglycerol signaling to mitogen-activated protein kinase in airway smooth muscle. Am J Physiol 1997; 273: 928-936.
58. Sosnowski J, Stetter NC, Cole D, Durham J.P., Mawhinney MG Protein kinase C mediated antiproliferative glucocorticoid-sphinganine synergism in cultured Pollard HI prostate tumor cells. J Urol. 1997; 158: 269-274.
59. Craven PA, Davidson CM, DeRubertis FR Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 1990; 39: 667-674.
60. Hoffman JM, Ishizuka T, Farese RV Interrelated effects of insulin and glucose on diacylglycerol-protein kinase-C signalling in rat adipcytes and solei muscle in vitro and in vivo in diabetic rats. Endocrinology 1991; 128: 2937-2949.
61. Lu Y, Morley P, Durkin JP Signalling events mediating the activation of protein kinase C by interleukin-2 in cytotoxic T cells. Cell Sig 1999; 11: 275-285.
62. Inoguchi T, Xia P, Kunisaki M., Higashi S, Feener EP, King GL Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am J Physiol 1994; 267: E1-E11.
63. Ways DK, Cook PP, Webter C, Prker PJ Effect of phorbol esters on protein kinase C-ζ J Biol Chem 1992; 267: 4799-4805,
64. Haller H, Baur E, Quass P., Behrend M, Lindschau C, Dinstler A., Luft FC High glucose concentrations and protein kinase C isoforms in vascular smooth muscle cells. Kidney International 1995; 47: 1057-1067
65. Stabel S. Ehe protein kinase C family, in growth factors, differentiation factors, and cytokines. Edited by habenicht A. springer verlag, Heidelberg 1990; 41: 414-426.
66. Nishizuka Y. Studies and perspectives of protein kinase C. Science 1986; 233: 305-312.
67. Tang EY, Parker PJ Beattie J, Houslay MD. Diabetes induces selective alterations in the expression of protein kinase C isoforms in hepatocytes. FEBS Lett. 1993; 326: 117-123.
68. Maruyama Y, Sakai Y, Nobe K., Momose K. Subcellular distribution of protein kinase C isoforms in gastric antrum smooth muscle of STZ-induced diabetic rats. Life Sci 1999; 64; 1933-1940.
69. Muniyappa R, Srinivas PR Ram JL, Walsh MF, Sowers JR. Calsium and protein kinase C mediate high-glucose-induced inhibition of inducible nitric oxide synthase in vascular smooth muscle cells. Hypertension 1998; 3: 289-295.
70. Chen CC, Liau CS, Lee YT Tumor necrosis factor-alpha, platelet-activating factor, and hydrogen peroxide activate protein kinase C subtypes alpha and epsilon in human saphenous vein endothelial cells. J Cardiovasc Pharmacol 1996; 28: 240-244.
71. Schmalz D, Kalkbrenner F, Hucho F., Buchner K. Transport of protein kinase C-α into the nucleus requires intact cytoskeleton while the transport of a protein containing a canonical nuclear localization signal does not. J Cell Sci 1996; 109: 2401-2406.
72. Zalewski PD, Forbes IJ, Glannakis C, Cowled P.A., Betts WH Synergy between zinc and phorbol ester in translocation of protein kinase C to cytoskeleton. FEBS Lett 1990; 273: 131-134.
73. Lee YH, Kim I, Laporte R., Walsh MP, Morgan KG Isozyme specific inhibitors of protein kinase C translocation: effects on contractility of single permea-bilized vascular muscle cells of the ferret. J Physiol 1999; 517: 709-720.
74. Sobue K, Sellers J, Caldesmon RA A novel regulatory protein in smooth muscle and nonmuscle actomyosin systems. J Biol Chem 1991; 266: 12115-12118.
75. Tanaka T, Ohta H, Kanda K., Tanaka T, Hidaka H, Sobue K. Phosphorylation of high-Mr caldesmon by protein kinase C modulates the regulatory function of this protein on the interaction between actin and myosin. Eur J Biochem 1990; 188: 495-500.
76. Janmey P.A. The cytoskeleton and cell signaling: component localization and mechanical coupling. Physiol Rev 1998; 78: 763-781.
77. Ishii H, Jirousek MR, Koya D et al. Amelioration of vascular dys-functions in diabetic rats by an oral PKC β inhibitor. Science 1996; 272: 728-731.
78. Park JY, Ha SW, King GL The role of protein kinase C activation in the pathogenesis of diabetic vascular complications. Perit Dial Int 1999; 19: 222-227.
79. Leventhal PS, Bertics PJ Activation of protein kinase C by selective binding of arginine-rich polypeptides. J Biol Chem 1993; 268: 13906-13913.
80. Khan WA, Blobe GC, Hannun YA Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C. Cell Sig 1995; 7: 171-184.
81. Dennis EA. Diversity of group types, regulation, and function of phospholipase AZ. J Biol Chem 1994; 269: 13057-13060.
82. Shinomura T, Asaoka Y, Oka M, Yoshida K, Nishizuka Y Synergistic action of diacylglycerol and unsaturated fatty acid for protein kinase C activation: its possible implications. Proc Natl Acad Sci U.S.A. 1991; 88: 5149-5153.
83. Shearman MS., Naor Z, Sekiguchi K., Kishimoto A, Nishizuka Y. Selective activation of the gamma-subspecies of protein kinase C from bovine cerebellum by arachidonic acid and its lipoxygenase metabolites. FEBS Lett 1989; 243: 177-182.
84. Khan WA, Blobe GC, Richards A.L., Hnnun YA Identification, partial purificatio, and characterization of a novel phospholopid-dependent and fatty acid-activated protein kinase from human platelets. J Biol Chem 1994; 269: 9729-9735.
85. Langlands JM, Diamond J. Translocation of protein kinase C in bovine tracheal smooth muscle strips: The effect of methacholine and isoprenaline. Eur J Pharmacol 1992; 227: 131-138.
86. Khalil RA, Morgan KG PKC-mediated redistribution of mitogen-activated protein kinase during smooth muscle cell activation. Am J Physiol 1993; 265: 406-411.
87. 2+ sensitization of myosin light chain phosphorylation in smooth muscle. Biochem J 1996; 318: 469-475.
88. Taggart MJ, Lee YH and Morgan KG. Cellular redistribution of PKC-α, rhoA, ROK-α following smooth muscle agonist stimulation experimental. Cell Res 1999; 251: 92-101
89. Khalil RA, Morgan KG Phenylephrine-induced translocation of protein kinase C and shortening of two types of vascular cells of the ferret. J Physiol 1992; 455: 585-599.
90. Khalil RA, Morgan KG Imaging of protein kinase C distribution and translocation in living vascular smooth muscle cells. Circ Res 1991; 69: 1626-1631.
91. Ali SM, Becker W, Davis M.G., Dorn GW II. Dissociation of vasoconstrictor-stimulated fibroblast growth factor expression from hypertrophic growth in cultural vascular smooth muscle cells: Relevant roles of protein kinase C. Circ Res 1994; 75: 836-843.
92. 2+ independent isoforms of protein kinase C differntially translocate in smooth muscle. Am J Physiol 1992; 263: C714-C719.
93. Sakai Y, Nobe K, Ohata H., Momose K. Contraction and protein kinase C distribution in rat gastric smooth muscle. Jpn J Pharmacol 1996; 71: 160.
94. Haller H, Lindschau C, Maasch C., Olthoff H Kurscheid D, Luft FC. Integrin-induced protein kinase C-α and C-ε translocation to focal adhesions mediates vascular smooth muscle cell spreading. Circ Res 1998; 82: 157-165.
95. Walker LA, Gailly P, Jensen P.E., Somlyo AV, Somlyo AP The unimportance of being (Protein kinase C) epsilon. FASEB J 1998; 12: 813-821.
96. 2+ dependence of smooth musc e contraction. J Biol Chem 1992; 267: 11839-11845.
97. Hartshorne DJ. Ito M, Erdodi F. Myosin light chain phosphatase: subunit composition, interactions and regulation. J. Muscle Res Cell Motil 1998; 19: 325-341.
98. Meininger GA, Moore EDW, Schmidt DJ, Lifshits I.M. and Fay FS. Distribution of active protein kinase C in smooth muscle. Biophys J 1999. 77: 973-984.
99. Clement CO, Walsh MP Identification of protein kinase C isozymes in smooth muscle: partial purification and characterization of chicken gizzard PKCζ. Biochem Cell Biol 1996; 74: 51-65.
100. 2+-regulation of insulin sensitivity. J Nutr 1995; 125: 1738S-1743S.
101. Biancani P, Harnett KM, Sohn U.D., Rhim BY, Behar J, Hillemeter C and Bitar KN. Differential signal transduction pathways in LES tone and response to ACh. Am J Physiol 1994; 266: G767-G774.
102. Sohn UD, Harnett KM, Cao W, Rich H., Kim N, Jbehar and Biancani P. Acute experimental esophagitis activates a second signal transduction pathway in cat smooth muscle from the lower esophageal sphincter. JPET 1997; 283: 1293-1304.
103. Avena R, Mitchell ME, Carmody B, Arora S., Neville RF, Sidaway AN Insulin-like growth factor-1 receptors mediate infragenicular vascular smooth muscle cell proliferation in response to glucose and insulin not by insulin receptors. Am J Surg 1999; 178: 156-161.
104. Arnqvist HJ, Bornfeldt KE, Chen Y, Lindstrom T. The insulin-like growth factor system in vascular smooth muscle: interaction with insulin and growth factors. Metabolism 1995; 44: 58-66.
105. Bornfelde KE, Raines EW, Nakano T, Graves L.M, Krebs EG, Ross R. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest 1994; 93: 1266-1274.
106. Bornfeldt KE, Arnqvist HJ, Capron L. In vivo proliferation of rat vascular smooth muscle in relation to diabetes mellitus insulin-like growth factor-I and insulin. Diabetologia 1992; 35: 104-108.
107. Schriever C, Schmidt A, Breithardt G., Buddecke E. Human recombinant insulin-like growth factor-I and -II stimulate the expression of basic fibroblast growth factor but suppress the division of bovine coronary smooth muscle cells. Atherosclerosis 1996; 122: 255-263.
108. Kuemmerle JF, Bushman TL IGF-I stimulates intestinal muscle cell growth by activating distinct PI3-kinase and MAP kinase pathways. Am J Physiol 1998; 275: G151-G158.